These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mechanisms of action of otilonium bromide (OB) in human cultured smooth muscle cells and rat colonic strips. Martínez-Cutillas M; Gil V; Gallego D; Mañé N; Martín MT; Jiménez M Neurogastroenterol Motil; 2013 Dec; 25(12):e803-12. PubMed ID: 23941257 [TBL] [Abstract][Full Text] [Related]
6. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes. Waelbroeck M; Lazareno S; Pfaff O; Friebe T; Tastenoy M; Mutschler E; Lambrecht G Br J Pharmacol; 1996 Dec; 119(7):1319-30. PubMed ID: 8968538 [TBL] [Abstract][Full Text] [Related]
7. Effect of otilonium bromide on contractile patterns in the human sigmoid colon. Gallego D; Aulí M; Aleu J; Martínez E; Rofes L; Martí-Ragué J; Jiménez M; Clavé P Neurogastroenterol Motil; 2010 Jun; 22(6):e180-91. PubMed ID: 20367799 [TBL] [Abstract][Full Text] [Related]
8. Otilonium bromide inhibits muscle contractions via L-type calcium channels in the rat colon. Martin MT; Hove-Madsen L; Jimenez M Neurogastroenterol Motil; 2004 Apr; 16(2):175-83. PubMed ID: 15086871 [TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with otilonium bromide induces changes in L-type Ca²⁺ channel, tachykinins, and nitric oxide synthase expression in rat colon muscle coat. Traini C; Cipriani G; Evangelista S; Santicioli P; Faussone-Pellegrini MS; Vannucchi MG Neurogastroenterol Motil; 2013 Nov; 25(11):e728-39. PubMed ID: 23901937 [TBL] [Abstract][Full Text] [Related]
10. Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations. Wess J; Lambrecht G; Mutschler E; Brann MR; Dörje F Br J Pharmacol; 1991 Jan; 102(1):246-50. PubMed ID: 2043926 [TBL] [Abstract][Full Text] [Related]
11. Inner and outer portions of colonic circular muscle: ultrastructural and immunohistochemical changes in rat chronically treated with otilonium bromide. Traini C; Faussone-Pellegrini MS; Evangelista S; Mazzaferro K; Cipriani G; Santicioli P; Vannucchi MG PLoS One; 2014; 9(8):e103237. PubMed ID: 25122192 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of selective muscarinic receptor antagonists on guinea-pig ileal smooth muscle. Doods HN; Entzeroth M; Ziegler H; Mayer N; Holzer P Eur J Pharmacol; 1994 Mar; 253(3):275-81. PubMed ID: 8200421 [TBL] [Abstract][Full Text] [Related]
16. Fluorescent styryl dyes FM1-43 and FM2-10 are muscarinic receptor antagonists: intravital visualization of receptor occupancy. Mazzone SB; Mori N; Burman M; Palovich M; Belmonte KE; Canning BJ J Physiol; 2006 Aug; 575(Pt 1):23-35. PubMed ID: 16728454 [TBL] [Abstract][Full Text] [Related]
17. Binding and functional properties of antimuscarinics of the hexocyclium/sila-hexocyclium and hexahydro-diphenidol/hexahydro-sila-diphenidol type to muscarinic receptor subtypes. Waelbroeck M; Tastenoy M; Camus J; Christophe J; Strohmann C; Linoh H; Zilch H; Tacke R; Mutschler E; Lambrecht G Br J Pharmacol; 1989 Sep; 98(1):197-205. PubMed ID: 2804545 [TBL] [Abstract][Full Text] [Related]
18. Binding characteristics and functional G protein coupling of muscarinic acetylcholine receptors in rat duodenum smooth muscle membranes. Liebmann C; Nawrath S; Schnittler M; Schubert H; Jakobs KH Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):7-15. PubMed ID: 1538792 [TBL] [Abstract][Full Text] [Related]